ANSWER TO THE TERESA PUSIOL COMMENTS TO THE PAPER "THE ASSOCIATION OF TUMOR LYMPHOCYTE INFILTRATION WITH CLINICO-PATHOLOGICAL FACTOR AND SURVIVAL IN BREAST CANCER" BY HUSZNO ET AL.

被引：1
作者：
Huszno, Joanna [1 ]
Zembala-Nozynska, Ewa [2 ]
Lange, Dariusz [2 ]
Kolosza, Zofia [3 ]
Nowara, Elzbieta [1 ]
机构：
[1] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Clin & Expt Oncol Dept, Gliwice Branch, Gliwice, Poland
[2] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Tumor Pathol Dept, Gliwice Branch, Gliwice, Poland
[3] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Epidemiol & Silesia Canc Registry, Gliwice Branch, Gliwice, Poland
来源：
POLISH JOURNAL OF PATHOLOGY | 2017年 / 68卷 / 03期
关键词：
TRIAL;
D O I：
10.5114/pjp.2017.71537
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：269 / 269
页数：1
相关论文
共 8 条
  • [1] THE ASSOCIATION OF TUMOR LYMPHOCYTE INFILTRATION WITH CLINICOPATHOLOGICAL FACTORS AND SURVIVAL IN BREAST CANCER
    Huszno, Joanna
    Nozynska, Ewa Zembala
    Lange, Dariusz
    Kolosza, Zofia
    Nowara, Elzbieta
    [J]. POLISH JOURNAL OF PATHOLOGY, 2017, 68 (01) : 26 - 32
  • [2] Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials
    Kotoula, Vassiliki
    Chatzopoulos, Kyriakos
    Lakis, Sotiris
    Alexopoulou, Zoi
    Timotheadou, Eleni
    Zagouri, Flora
    Pentheroudakis, George
    Gogas, Helen
    Galani, Eleni
    Efstratiou, Ioannis
    Zaramboukas, Thomas
    Koutras, Angelos
    Aravantinos, Gerasimos
    Samantas, Epaminontas
    Psyrri, Amanda
    Kourea, Helen
    Bobos, Mattheos
    Papakostas, Pavlos
    Kosmidis, Paris
    Pectasides, Dimitrios
    Fountzilas, George
    [J]. ONCOTARGET, 2016, 7 (04) : 5074 - 5087
  • [3] Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
    Loi, S.
    Michiels, S.
    Salgado, R.
    Sirtaine, N.
    Jose, V.
    Fumagalli, D.
    Kellokumpu-Lehtinen, P-L
    Bono, P.
    Kataja, V.
    Desmedt, C.
    Piccart, M. J.
    Loibl, S.
    Denkert, C.
    Smyth, M. J.
    Joensuu, H.
    Sotiriou, C.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (08) : 1544 - 1550
  • [4] Manjili MH, 2012, FUTURE ONCOL, V8, P703, DOI [10.2217/fon.12.57, 10.2217/FON.12.57]
  • [5] Beyond immune density: critical role of spatial heterogeneity in estrogen receptor-negative breast cancer
    Nawaz, Sidra
    Heindl, Andreas
    Koelble, Konrad
    Yuan, Yinyin
    [J]. MODERN PATHOLOGY, 2015, 28 (06) : 766 - 777
  • [6] Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial
    Perez, Edith A.
    Thompson, E. Aubrey
    Ballman, Karla V.
    Anderson, S. Keith
    Asmann, Yan W.
    Kalari, Krishna R.
    Eckel-Passow, Jeanette E.
    Dueck, Amylou C.
    Tenner, Kathleen S.
    Jen, Jin
    Fan, Jian-Bing
    Geiger, Xochiquetzal J.
    McCullough, Ann E.
    Chen, Beiyun
    Jenkins, Robert B.
    Sledge, George W.
    Winer, Eric P.
    Gralow, Julie R.
    Reinholz, Monica M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07) : 701 - 708
  • [7] Rathore AS, 2014, INDIAN J MED RES, V140, P361
  • [8] Prognostic Factors for Breast Cancer: an Immunomorphological Update
    Roncati, Luca
    Barbolini, Giuseppe
    Piacentini, Federico
    Piscioli, Francesco
    Pusiol, Teresa
    Maiorana, Antonio
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (03) : 449 - 452
1